-+ 0.00%
-+ 0.00%
-+ 0.00%

MABION SA - RECEIVES US FDA CONFIRMATION FOR PRE-IND TYPE B MEETING ON OCT 5 REGARDING MABIONCD20 AS ORPHAN DRUG FOR IMMUNE THROMBOCYTOPENIA

Reuters·08/26/2026 11:24:30

Please log in to view news